Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer

BJU International

Volumn 105, Issue 11, 2010, Pages 1548-1552

  Suardi, Nazareno ^a   Briganti, Alberto ^a   Gallina, Andrea ^a   Salonia, Andrea ^a   Karakiewicz, Pierre I ^b   Capitanio, Umberto ^a   Freschi, Massimo ^a   Cestari, Andrea ^a   Guazzoni, Giorgio ^a   Rigatti, Patrizio ^a   Montorsi, Francesco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Active surveillance; Prostate cancer; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER INVASION; GLEASON SCORE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PATIENT SELECTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SEMINAL VESICLES;

EID: 77952188566     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.09057.x     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008 58 : 71 96 (Pubitemid 351521864)
2. Hardie C, Parker C, Norman A et al. Early outcomes of active surveillance for localized prostate cancer. BJU Int 2005 95 : 956 960 (Pubitemid 40655686) (Pubitemid 40655686)
3. Soloway MS, Soloway CT, Williams S, Ayyathurai R, Kava B, Manoharan M. Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience. BJU Int 2008 101 : 165 169 (Pubitemid 350294039)
4. Klotz L. Active surveillance for prostate cancer: for whom? J Clin Oncol 2005 23 : 8165 8169 (Pubitemid 46211550)
5. van den Bergh RC, Roemeling S, Roobol MJ et al. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur Urol 2009 (in press)
6. Carter HB, Walsh PC, Landis P, Epstein JI. Expectant management of nonpalpable prostate cancer with curative intent: preliminary results. J Urol 2002 167 : 1231 1234 (Pubitemid 34132060)
7. Carter HB, Kettermann A, Warlick C et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol 2007 178 : 2359 2365 (Pubitemid 350052183)
8. Ercole B, Marietti SR, Fine J, Albertsen PC. Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era. J Urol 2008 180 : 1336 1341
9. Roemeling S, Roobol MJ, de Vries SH et al. Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome. Eur Urol 2007 51 : 1244 51 (Pubitemid 46436308)
10. Stattin P, Holmberg E, Bratt O, Adolfsson J, Johansson JE, Hugosson J. Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden. J Urol 2008 180 : 2423 2430
11. Venkitaraman R, Norman A, Woode-Amissah R et al. Predictors of histological disease progression in untreated, localized prostate cancer. J Urol 2007 178 : 833 837 (Pubitemid 47211073)
12. Warlick C, Trock BJ, Landis P, Epstein JI, Carter HB. Delayed versus immediate surgical intervention and prostate cancer outcome. J Natl Cancer Inst 2006 98 : 355 357 (Pubitemid 43338215)
13. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994 271 : 368 374 (Pubitemid 24037911)
14. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988 12 : 897 906
15. Choo R, Klotz L, Danjoux C et al. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 2002 167 : 1664 1669 (Pubitemid 34240696)
16. Suardi N, Capitanio U, Chun FK et al. Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features. Cancer 2008 113 : 2068 2072
17. van As NJ, Norman AR, Thomas K et al. Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance. Eur Urol 2008 54 : 1297 1305
18. Dall'Era MA, Konety BR, Cowan JE et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 2008 112 : 2664 2670 (Pubitemid 351969209)
19. Nakanishi H, Wang X, Ochiai A et al. A nomogram for predicting low-volume /low-grade prostate cancer: a tool in selecting patients for active surveillance. Cancer 2007 110 : 2441 2447 (Pubitemid 350174929)
20. van den Bergh RC, Roemeling S, Roobol MJ et al. Gleason score 7 screen-detected prostate cancers initially managed expectantly: outcomes in 50 men. BJU Int 2009 103 : 1472 1477
21. Berglund RK, Masterson TA, Vora KC, Eggener SE, Eastham JA, Guillonneau BD. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance. J Urol 2008 180 : 1964 1968
22. Choo R, Danjoux C, Morton G et al. How much does Gleason grade of follow-up biopsy differ from that of initial biopsy in untreated, Gleason score 4-7, clinically localized prostate cancer? Prostate 2007 67 : 1614 1620 (Pubitemid 350036947)
23. Chun FK, Briganti A, Shariat SF et al. Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation. BJU Int 2006 98 : 329 334
24. Capitanio U, Karakiewicz PI, Jeldres C et al. The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predicted. Int J Urol 2009 16 : 526 529
25. Barocas DA, Cowan JE, Smith JA Jr., Carroll PR. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. J Urol 2008 180 : 1330 1335